Gestational hypertensions: Definitions and consequences in outcome of pregnancy;Définitions et conséquences des hypertensions artérielles de la grossesse

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 3, 2010, Pages

  Berkane, N ^a  

^a HÔPITAL TENON   (France)

Author keywords

Definition of preeclampsia; Gestational hypertension; HELLP syndrom; Hypertensive disorders in pregnancy; Preeclampsia; Pregnancy

Indexed keywords

AMENORRHEA; ARTICLE; BIRTH WEIGHT; DIASTOLIC BLOOD PRESSURE; ECLAMPSIA; EPIGASTRIC PAIN; GESTATIONAL AGE; HELLP SYNDROME; HEMOLYSIS; HUMAN; HYPERREFLEXIA; HYPERURICEMIA; MATERNAL HYPERTENSION; MORBIDITY; MORTALITY; PREECLAMPSIA; PROTEINURIA; PUERPERIUM; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; ECLAMPSIA; FEMALE; FETAL DEATH; FETUS; HELLP SYNDROME; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROTEINURIA; TERMINOLOGY AS TOPIC;

EID: 77952544679     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.02.003     Document Type: Article

References (35)

1. Askie L.M., Duley L., Henderson-Smart D.J., Stewart L.A. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007, 369:1791-1798.
2. Abenhaim H.A., Kinch R.A., Morin L., Benjamin A., Usher R. Effect of prepregnancy body mass index categories on obstetrical and neonatal outcomes. Arch Gynecol Obstet 2007, 275:39-43.
3. United NPF. Maternal mortality update 2002-a focus on emergency obstetric care. New York: UNFPA; 2003.
4. National High Blood Pressure Education Program Working Group. Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990;163:1691-712.
5. Davey D.A., MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988, 158:892-898.
6. ACOG technical bulletin. Hypertension in pregnancy. Number 219 - January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996;53:175-83.
7. Moutquin J.M., Rainville C., Giroux L., Raynauld P., Amyot G., Bilodeau R., et al. A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol 1985, 151:191-196.
8. Villar M.A., Sibai B.M. Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during third trimester. Am J Obstet Gynecol 1989, 160:419-423.
9. Brown M.A., Buddle M.L. Inadequacy of dipstick proteinuria in hypertensive pregnancy. Aust N Z J Obstet Gynaecol 1995, 35:366-369.
10. Redman C.W., Jefferies M. Revised definition of pre-eclampsia. Lancet 1988, 1:809-812.
11. Zadehmodarres S., Razzaghi M.R., Habibi G., Najmi Z., Jam H., Mosaffa N., et al. Random urine protein to creatinine ratio as a diagnostic method of significant proteinuria in pre-eclampsia. Aust N Z J Obstet Gynaecol 2006, 46:501-504.
12. Perry I.J., Beevers D.G. The definition of pre-eclampsia. Br J Obstet Gynaecol 1994, 101:587-591.
13. Sibai B.M., Kustermann L., Velasco J. Current understanding of severe preeclampsia, pregnancy-associated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, hemolysis, elevated liver enzymes, and low platelet syndrome, and postpartum acute renal failure: different clinical syndromes or just different names?. Curr Opin Nephrol Hypertens 1994, 3:436-445.
14. Repke J.T. Hypertensive disorders of pregnancy. Differentiating preeclampsia from active systemic lupus erythematosus. J Reprod Med 1998, 43:350-354.
15. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
16. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982, 142:159-167.
17. Douglas K.A., Redman C.W. Eclampsia in the United Kingdom. BMJ 1994, 309:1395-1400.
18. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
19. Berkane N., Lefevre G., Hertig A. Angiogenic factors in preeclampsia: so complex, so simple?. Nephrol Dial Transplant 2007, 22:2753-2756.
20. Levine R.J., Lam C., Qian C., Yu K.F., Maynard S.E., Sachs B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006, 355:992-1005.
21. Waterstone M., Bewley S., Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001, 322. 1089-93; discussion 1093-4.
22. Zhang W.H., Alexander S., Bouvier-Colle M.H., Macfarlane A. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. Bjog 2005, 112:89-96.
23. Chhabra S., Kakani A. Maternal mortality due to eclamptic and non-eclamptic hypertensive disorders: a challenge. J Obstet Gynaecol 2007, 27:25-29.
24. MacKay A.P., Berg C.J., Atrash H.K. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001, 97:533-538.
25. Gaugler-Senden I.P., Huijssoon A.G., Visser W., Steegers E.A., de Groot C.J. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation Audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol 2006, 128:216-221.
26. Subramaniam V. Seasonal variation in the incidence of preeclampsia and eclampsia in tropical climatic conditions. BMC Womens Health 2007, 7:18.
27. Sibai B. Diagnosis, prevention and magement of preeclampsia. Obstet Gynecol 2005, 105:402-410.
28. Xiong X., Buekens P., Pridjian G., Fraser W.D. Pregnancy-induced hypertension and perinatal mortality. J Reprod Med 2007, 52:402-406.
29. Gul A., Cebeci A., Aslan H., Polat I., Sozen I., Ceylan Y. Perinatal outcomes of twin pregnancies discordant for major fetal anomalies. Fetal Diagn Ther 2005, 20:244-248.
30. Sobande A.A., Eskandar M., Bahar A., Abusham A. Severe pre-eclampsia and eclampsia in Abha, the south west region of Saudi Arabia. J Obstet Gynaecol 2007, 27:150-154.
31. Anastasiadis P., Tsikouras P., Galazios G., Liberis V., Grapsas X., Koutlaki N., et al. Hypertensive disorders in pregnancy: risk factors and epidemiologic analysis. Clin Exp Obstet Gynecol 2007, 34:154-158.
32. Habli M., Levine R.J., Qian C., Sibai B. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol 2007, 197. 406e1-7.
33. Jacquemyn Y., Osmanovic F., Martens G. Preeclampsia and birthweight by gestational age in singleton pregnancies in Flanders Belgium: a prospective study. Clin Exp Obstet Gynecol 2006, 33:96-98.
34. Chen X.K., Wen S.W., Smith G.N., Yang Q., Walker M.C. Pregnancy-induced hypertension and infant mortality in triplets. Int J Gynaecol Obstet 2007, 98:10-14.
35. Yu C.K., Papageorghiou A.T., Parra M., Palma Dias R., Nicolaides K.H. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 2003, 22:233-239.